Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Сравнительное изучение эффективности протоколов поддерживающей терапии после переноса эмбрионов в программах вспомогательных репродуктивных технологий
Сравнительное изучение эффективности протоколов поддерживающей терапии после переноса эмбрионов в программах вспомогательных репродуктивных технологий
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Daya S, Gunby J. Luteal phase support in assisted reproductive cycles. (Cochrane review). The Cochrane library. UK: John Wiley and Sons Ltd., 2004; 3.
2. Penzias AS. Luteal phase support. Fertil Steril 2002; 77 (2): 318–23.
3. Toner JP. The luteal phase: luteal support protocols. Textbook of assisted reproductive techniques. 2002; 515–25.
4. Сидельникова В.М. и др. Вопросы подготовки, особенности течения и тактика ведения беременности, возникшей в программе ЭКО. Экстракорпоральное оплодотворения и его новые направления в лечении женского и мужского бесплодия. 2000; 574.
5. Ludwig M, Schwartz P, Babahan A et al. Luteal phase support using eithercrinone 8% or uterogest: results of a prospective randomized study. Europ J Obstet Gynaecol 2002; 103: 48–52.
6. Nosarka S, Kruger T, Siebert I, Grove D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest 2005; 60 (2): 67–74.
7. Fanchin R, De ZD, Bergeron C et al. Trasvaginal administration progesterone. Obstet Gynecol 1997; 396.
8. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991; 56 (6): 1034–9.
9. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone areequally effective for luteal phase support in IVF. Gynecol Endorinol 2000; 14 (5): 316–20.
10. Damario MA, Goudas VT, Session DR et al. Crinone 8% vaginal progesterone gelresults in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril 1999; 72 (5): 829–36.
11. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8): 1944–8.
12. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76.
13. Anserini P, Costa M, Remorgida V et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53 (4): 297–301.
2. Penzias AS. Luteal phase support. Fertil Steril 2002; 77 (2): 318–23.
3. Toner JP. The luteal phase: luteal support protocols. Textbook of assisted reproductive techniques. 2002; 515–25.
4. Сидельникова В.М. и др. Вопросы подготовки, особенности течения и тактика ведения беременности, возникшей в программе ЭКО. Экстракорпоральное оплодотворения и его новые направления в лечении женского и мужского бесплодия. 2000; 574.
5. Ludwig M, Schwartz P, Babahan A et al. Luteal phase support using eithercrinone 8% or uterogest: results of a prospective randomized study. Europ J Obstet Gynaecol 2002; 103: 48–52.
6. Nosarka S, Kruger T, Siebert I, Grove D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest 2005; 60 (2): 67–74.
7. Fanchin R, De ZD, Bergeron C et al. Trasvaginal administration progesterone. Obstet Gynecol 1997; 396.
8. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991; 56 (6): 1034–9.
9. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone areequally effective for luteal phase support in IVF. Gynecol Endorinol 2000; 14 (5): 316–20.
10. Damario MA, Goudas VT, Session DR et al. Crinone 8% vaginal progesterone gelresults in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril 1999; 72 (5): 829–36.
11. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8): 1944–8.
12. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76.
13. Anserini P, Costa M, Remorgida V et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53 (4): 297–301.
2. Penzias AS. Luteal phase support. Fertil Steril 2002; 77 (2): 318–23.
3. Toner JP. The luteal phase: luteal support protocols. Textbook of assisted reproductive techniques. 2002; 515–25.
4. Сидельникова В.М. и др. Вопросы подготовки, особенности течения и тактика ведения беременности, возникшей в программе ЭКО. Экстракорпоральное оплодотворения и его новые направления в лечении женского и мужского бесплодия. 2000; 574.
5. Ludwig M, Schwartz P, Babahan A et al. Luteal phase support using eithercrinone 8% or uterogest: results of a prospective randomized study. Europ J Obstet Gynaecol 2002; 103: 48–52.
6. Nosarka S, Kruger T, Siebert I, Grove D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest 2005; 60 (2): 67–74.
7. Fanchin R, De ZD, Bergeron C et al. Trasvaginal administration progesterone. Obstet Gynecol 1997; 396.
8. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991; 56 (6): 1034–9.
9. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone areequally effective for luteal phase support in IVF. Gynecol Endorinol 2000; 14 (5): 316–20.
10. Damario MA, Goudas VT, Session DR et al. Crinone 8% vaginal progesterone gelresults in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril 1999; 72 (5): 829–36.
11. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8): 1944–8.
12. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76.
13. Anserini P, Costa M, Remorgida V et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53 (4): 297–301.
________________________________________________
2. Penzias AS. Luteal phase support. Fertil Steril 2002; 77 (2): 318–23.
3. Toner JP. The luteal phase: luteal support protocols. Textbook of assisted reproductive techniques. 2002; 515–25.
4. Сидельникова В.М. и др. Вопросы подготовки, особенности течения и тактика ведения беременности, возникшей в программе ЭКО. Экстракорпоральное оплодотворения и его новые направления в лечении женского и мужского бесплодия. 2000; 574.
5. Ludwig M, Schwartz P, Babahan A et al. Luteal phase support using eithercrinone 8% or uterogest: results of a prospective randomized study. Europ J Obstet Gynaecol 2002; 103: 48–52.
6. Nosarka S, Kruger T, Siebert I, Grove D. Luteal Phase Support in in vitro Fertilization: Meta-Analysis of Randomized Trials. Gyn Obstet Invest 2005; 60 (2): 67–74.
7. Fanchin R, De ZD, Bergeron C et al. Trasvaginal administration progesterone. Obstet Gynecol 1997; 396.
8. Norman TR, Morse CA, Dennerstein L. Comparative bioavailability of orally and vaginally administered progesterone. Fertil Steril 1991; 56 (6): 1034–9.
9. Martinez F, Coroleu B, Parera N. Human chorionic gonadotropin and intra-vaginal natural progesterone areequally effective for luteal phase support in IVF. Gynecol Endorinol 2000; 14 (5): 316–20.
10. Damario MA, Goudas VT, Session DR et al. Crinone 8% vaginal progesterone gelresults in lower embryonic implantation efficiency after in vitro fertilization- embryo transfer. Fertil Steril 1999; 72 (5): 829–36.
11. Friedler S, Raziel A, Schachter M. Luteal support with micronized progesterone following in vitro fertilization using a down regulation protocol with gonadotropin releasing hormone agonist: a comparative study between vaginal and oral administration. Hum Reprod 1999; 14 (8): 1944–8.
12. Soliman S, Daya S, Collins J, Hughes EG. The role of luteal phase support in infertility treatment: a meta-analysis of randomized trials. Fertil Steril 1994; 61: 1068–76.
13. Anserini P, Costa M, Remorgida V et al. Luteal phase support in assisted reproductive cycles using either vaginal (crinone 8%) or intramuscular (prontogest) progesterone: results of a prospective randomized study. Minerva Ginecol 2001; 53 (4): 297–301.
Авторы
Д.П.Камилова, Т.В.Овсянникова, А.А.Феоктистов, Д.А.Давыдова
НОУ Учебный центр последипломного образования врачей, Клиника «Мать и дитя», Москва
НОУ Учебный центр последипломного образования врачей, Клиника «Мать и дитя», Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.